Content about National Association of Chain Drug Stores

ALEXANDRIA, Va. — The National Association of Chain Drug Stores on Monday recognized U.S. Sen. Kay Hagan (D-N.C.) for her continued leadership on behalf of pharmacy patient care. Hagan, joined by seven U.S. Senate colleagues, sent a bipartisan letter of support for medication therapy management to U.S. Senate Majority Leader Harry Reid and Minority Leader Mitch McConnell.

ALEXANDRIA, Va. — The 14th annual National Association of Chain Drug Stores Foundation dinner raised nearly $1.8 million to fund research, charity and scholarships, the foundation said Wednesday.

ALEXANDRIA, Va. — As the U.S. Senate and House of Representatives examined the meningitis outbreak this week, the National Association of Chain Drug Stores distinguished between the types of pharmacy compounding and the settings in which they take place, and emphasized the critical, life-saving benefits of pharmacy compounding.

NACDS stated that it has sent a letter to members of the U.S. Senate Committee on Health, Education, Labor and Pensions and the U.S. House Committee on Energy and Commerce — both of which held hearings on the outbreak on Nov. 14.

NEW YORK — Americans woke up Wednesday morning to the news that Barack Obama had won a second term as president of the United States. Some people may be happy about that, others unhappy and others neutral — but win or lose, the results of Tuesday's election affect everyone, including those in the retail pharmacy industry.

ALEXANDRIA, Va. — The National Association of Chain Drug Stores has announced that it will participate in the annual U.S. Senate Health Fair, which will take place on Oct. 11 to 12 in the U.S. Senate Office complex on Capitol Hill in Washington, D.C.  

The U.S. Senate Health Fair will offer thousands of Senate employees — including Hill staffers, Capitol Hill Police officers and other employees — an opportunity to receive healthcare advice and care, highlighting the essential role community pharmacy plays in the healthcare delivery system.  

WASHINGTON — Serving as co-chair of the 13th Annual Summit Awards Dinner — which was presented by the American Society of Association Executives - the Center for Association Leadership Wednesday evening at the National Building Museum in Washington, D.C. — National Association of Chain Drug Stores president and CEO Steve Anderson emphasized to more than 1,100 attendees that associations serve a vital function as the "fifth estate" in the 21st century American democracy.

“Drugs don’t work in patients who don’t take them.”

Sounds simple enough. But that obvious truism, voiced by former U.S. surgeon general C. Everett Koop, fails to convince tens of millions of patients that they should take their prescription medicines through the full dosage regimen. And in too many cases, patients aren’t even filling the script to begin with.

ALEXANDRIA, Va. — With less than six weeks until Election Day, the National Association of Chain Drug Stores grassroots advocacy program is in high gear with its NACDS RxImpact Votes program, urging pharmacy advocates to help shape pharmacy’s future through political engagement.

The nonpartisan NACDS RxImpact Votes program empowers pharmacy advocates with a toolkit of resources to show the role they can play in the election process. The program focuses its “get out the vote” campaign in three ways:

When National Association of Chain Drug Stores president and CEO Steve Anderson earlier this year at NACDS Annual urged pharmacy leaders to be “disruptive innovators,” and new NACDS chairman and Walgreens president and CEO Greg Wasson called on the industry to embrace a holistic view of the total store in improving patient lives, they easily could have submitted Walgreens and its Take Care Health Systems subsidiary as an ideal case study.


ALEXANDRIA, Va. — In a statement issued on Monday, the National Association of Chain Drug Stores applauded the U.S. Senate for its passage of the “Strengthening and Focusing Enforcement to Deter Organized Stealing and Enhance Safety Act of 2012,” also known as the “Safe Doses Act” (H.R. 4223 and S. 1002).  

The bill passed unanimously in the Senate on Sept. 22, and previously passed in the U.S. House of Representatives on June 26.

Over the last few years of DSN’s coverage of the impending patent cliff and how it would affect the generic drug industry, IMS Health VP industry relations Doug Long predicted that the gradual commoditization of primary care drugs — long the lifeblood of generic drug makers — would lead to consolidation of the industry.